GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Total Assets

RDTCF (Rapid Dose Therapeutics) Total Assets : $1.20 Mil (As of Nov. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Total Assets?

Rapid Dose Therapeutics's Total Assets for the quarter that ended in Nov. 2024 was $1.20 Mil.

During the past 12 months, Rapid Dose Therapeutics's average Total Assets Growth Rate was -10.80% per year. During the past 3 years, the average Total Assets Growth Rate was -22.90% per year. During the past 5 years, the average Total Assets Growth Rate was -9.80% per year.

During the past 13 years, Rapid Dose Therapeutics's highest 3-Year average Total Assets Growth Rate was 362.60%. The lowest was -56.70%. And the median was -10.30%.

Total Assets is connected with ROA %. Rapid Dose Therapeutics's annualized ROA % for the quarter that ended in Nov. 2024 was -318.43%. Total Assets is also linked to Revenue through Asset Turnover. Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Nov. 2024 was 0.29.


Rapid Dose Therapeutics Total Assets Historical Data

The historical data trend for Rapid Dose Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Total Assets Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.23 3.02 2.41 1.67 1.40

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.40 1.33 1.26 1.20

Rapid Dose Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rapid Dose Therapeutics's Total Assets for the fiscal year that ended in Feb. 2024 is calculated as

Total Assets=Total Equity (A: Feb. 2024 )+Total Liabilities (A: Feb. 2024 )
=-2.339+3.736
=1.40

Rapid Dose Therapeutics's Total Assets for the quarter that ended in Nov. 2024 is calculated as

Total Assets=Total Equity (Q: Nov. 2024 )+Total Liabilities (Q: Nov. 2024 )
=-2.937+4.132
=1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rapid Dose Therapeutics  (OTCPK:RDTCF) Total Assets Explanation

Total Assets is connected with ROA %.

Rapid Dose Therapeutics's annualized ROA % for the quarter that ended in Nov. 2024 is

ROA %=Net Income (Q: Nov. 2024 )/( (Total Assets (Q: Aug. 2024 )+Total Assets (Q: Nov. 2024 ))/ count )
=-3.904/( (1.257+1.195)/ 2 )
=-3.904/1.226
=-318.43 %

Note: The Net Income data used here is four times the quarterly (Nov. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Nov. 2024 is

Asset Turnover
=Revenue (Q: Nov. 2024 )/( (Total Assets (Q: Aug. 2024 )+Total Assets (Q: Nov. 2024 ))/ count )
=0.359/( (1.257+1.195)/ 2 )
=0.359/1.226
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rapid Dose Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines

From GuruFocus

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 07-28-2022

Rapid Dose Announces Revocation of Cease Trade Order

By Business Wire Business Wire 05-02-2023

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 08-25-2022

Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial Results

By Business Wire Business Wire 02-01-2023

Rapid Dose Announces Change of Auditor

By Business Wire Business Wire 05-17-2023